The cyclosporine plus everolimus regimen ( group CE , n = 32 ) was suggested first ; upon refusal or if the recipient or donor was positive for hepatitis B surface antigen or PCR + hepatitis C infection , then patient was randomly assigned to success cyclosporine plus mycophenolate mofetil ( MMF ; group CM , n = 24 ) or tacrolimus plus MMF ( group TM , n = 25 ) .
